YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer : Comparemela.com

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Hong Kong , Beijing , China , United States , Singapore , Philippines , Hui Shao , Dave Chenn , Robin Yang , Alyssa Li , China Green Energy Fund , Exchange Square , Securities Exchange , Company The Interim , Prnewswire Ys Biopharma Co Ltd , Source Ys Biopharma Co Ltd , Company The Board , Council Member , Company Registration Statement On Form , China Century Group , University Of Chicago Booth School Business , Ys Biopharma Co Ltd , Meeting Of The Company , Rsys Group , Lakeshore Biopharma Co Ltd , Institute Of Technology , Nasdaq , Oracle , Extraordinary General Meeting , Two Exchange Square , Eastern Time , Incentive Plan , Interim Chief Executive Officer , Chief Executive Officer , Co Chief Executive Officer , Chief Business Officer , Oceanpine Capital , Managing Partner , Southeast Asia , Silicon Valley , Advisory Board Member , Booth School , Vice Chairman , Beijing Institute , Green Energy Fund , Top Ten Reformer , Innovation Leader , Top Ten Biopharma Investors , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Post Effective Amendment , Registration Statement ,

comparemela.com © 2020. All Rights Reserved.